Patients on long-term dialysis face an elevated risk of cancer, and among Chinese dialysis patients urothelial carcinoma stands out for both its high incidence and its distinctive clinical behavior. A new retrospective study from a national center in Beijing asks a question that has remained poorly resolved: does it matter whether urothelial carcinoma develops before dialysis begins, or only after a patient has already started treatment? The answer, according to the analysis of 100 patients operated on between 2000 and 2021, appears to be yes, with important implications for how this vulnerable group is monitored.
The research team, publishing in BMC Urology, divided their cohort into two groups. Thirty-seven patients had urothelial carcinoma both before and after starting dialysis, meaning the disease was already present or emerged around the time their kidney failure treatment began. The remaining 63 patients developed urothelial carcinoma exclusively after dialysis initiation. The investigators compared demographics, clinical characteristics and oncological outcomes between the groups, using Kaplan–Meier curves and log-rank tests to assess recurrence-free survival, overall survival and cancer-specific survival, and Cox regression to identify factors independently associated with death.
The headline finding concerns survival. Patients whose cancer appeared only after dialysis had significantly worse overall survival, with a log-rank p value of 0.0207. Cancer-specific survival also trended in the same direction, with these patients faring poorer, though the difference did not reach conventional statistical significance (log-rank p = 0.1011). Because this was a single-center retrospective cohort, the results describe associations within this particular population rather than proving that the timing of cancer onset directly causes worse outcomes, but the pattern was consistent enough that the authors argue tailored management is needed.
The two groups also differed in composition. The post-dialysis-only group contained a markedly higher proportion of women, 74.60 percent compared with 56.76 percent among patients whose disease straddled the dialysis threshold.
Within the post-dialysis-only group, the Cox regression analysis identified age and a history of alcohol use as independent risk factors for mortality. Separately, across the cohort, anuria, the complete loss of urine output, was associated with worse recurrence-free survival (p = 0.045, log-rank p = 0.033).
What the Beijing team adds is a temporal dimension. Prior work has documented that Chinese dialysis patients experience elevated urothelial cancer risk overall, but how the timing of tumor development relative to the first dialysis session shapes clinical behavior and long-term survival had remained unclear, a gap the authors say has hindered the design of targeted surveillance strategies.
The practical implication is that surveillance should not be uniform.
As with any single-center retrospective study, the findings come with caveats. The cancer-specific survival comparison, while suggestive, did not reach statistical significance, and the mortality risk factors were identified only within the post-dialysis-only subgroup. Still, for a population already facing heightened cancer risk, the study offers a concrete starting point for deciding who needs the closest watch.
Subject of Research: Survival outcomes of urothelial carcinoma developing before versus after dialysis initiation in Chinese dialysis patients
Article Title: Urothelial carcinoma in Chinese dialysis patients: a 20-year single-center retrospective cohort study of pre- and post-dialysis development
Article References: Xie, J., Zhou, P., Zhu, J., Liu, Y., Li, Z., Sun, Z., Yun, Y., Hao, H., & Yu, W. (2026). Urothelial carcinoma in Chinese dialysis patients: a 20-year single-center retrospective cohort study of pre- and post-dialysis development. BMC Urology. https://doi.org/10.1186/s12894-026-02429-2
Image Credits: AI Generated
DOI: 10.1186/s12894-026-02429-2
Keywords: urothelial carcinoma, dialysis, chronic kidney disease, retrospective cohort, overall survival, recurrence-free survival, anuria, bladder cancer, China, cancer surveillance, Urothelial, carcinoma
News Source: Jerry Hayes. (October 28, 2026). Urothelial carcinoma after dialysis start linked to poorer survival in Chinese cohort. Scienmag.
